MedPath

Comparing the efficacy of a combination of Mometasone and Olopatadine sprays versus Mometasone spray in children with allergic rhinitis

Phase 3
Recruiting
Conditions
Allergic rhinitis.
Vasomotor and allergic rhinitis
Registration Number
IRCT20150426021944N5
Lead Sponsor
Oroumia University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
80
Inclusion Criteria

Allergic rhinitis diagnosis by a clinical allergist collaborating in the project (based on the presence of clinical symptoms such as sneezing, nasal congestion, nasal secretions, and nasal itching or based on a positive prick test or a positive IgE specific to allergens)
Age 6-12 years old
Obtaining written informed consent from parents

Exclusion Criteria

Known history of nasal polyps, other clinically significant respiratory system abnormalities
Structural abnormalities of the nose
Septum deviation
Chronic, acute, or significant sinusitis or post-nasal drip (PND)
Drug-induced rhinitis; active pulmonary disorder or infection (e.g., bronchitis, pneumonia, or influenza)
Upper respiratory tract or sinus infection within the past 14 days
Other important clinical abnormalities of the respiratory system

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath